FDA Approves ISEMBYLD™ for People Living with SMA

SCHAUMBURG, Ill., Sept. 14, 2026 /PRNewswire/ -- Cure SMA, the leading nonprofit organization supporting those impacted by spinal muscular atrophy (SMA), celebrates that Scholar Rock announced FDA approval of ISEMBYLD™ (apitegromab-mstn) to treat people living with SMA. This approval...